Abstract:Many regulations are beginning to explicitly require investigation of a chemical's endocrine-disrupting properties as a part of the safety assessment process for substances already on or about to be placed on the market. Different jurisdictions are applying distinct approaches. However, all share a common theme requiring testing for endocrine activity and adverse effects, typically involving in vitro and in vivo assays on selected endocrine pathways. For ecotoxicological evaluation, in vivo assays can be performed across various animal species, including mammals, amphibians, and fish. Results indicating activity (i.e., that a test substance may interact with the endocrine system) from in vivo screens usually trigger further higher-tier in vivo assays. Higher-tier assays provide data on adverse effects on relevant endpoints over more extensive parts of the organism's life cycle. Both in vivo screening and higher-tier assays are animal- and resource-intensive and can be technically challenging to conduct. Testing large numbers of chemicals will inevitably result in the use of large numbers of animals, contradicting stipulations set out within many regulatory frameworks that animal studies be conducted as a last resort. Improved strategies are urgently required. In February 2020, the UK's National Centre for the 3Rs and the Health and Environmental Sciences Institute hosted a workshop ("Investigating Endocrine Disrupting Properties in Fish and Amphibians: Opportunities to Apply the 3Rs"). Over 50 delegates attended from North America and Europe, across academia, laboratories, and consultancies, regulatory agencies, and industry. Challenges and opportunities in applying refinement and reduction approaches within the current animal test guidelines were discussed, and utilization of replacement and/or new approach methodologies, including in silico, in vitro, and embryo models, was explored. Efforts and activities needed to enable application of 3Rs approaches in practice were also identified. This article provides an overview of the workshop discussions and sets priority areas for follow-up. Integr Environ Assess Manag 2022;18:442-458. © 2021 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).

Examining animal testing for risk assessment: A WC-12 workshop report

Consensus report on the future of animal-free systemic toxicity testing

Integrating emerging science to improve estimates of risk to wildlife from chemical exposure: What are the challenges?

State of the science on alternatives to animal testing and integration of testing strategies for food safety assessments: Workshop proceedings

Wildlife Ecological Risk Assessment in the 21st Century: Promising Technologies to Assess Toxicological Effects

New approach methodologies in human regulatory toxicology - Not if, but how and when!

Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods

Advancing Risk Analysis for Nanoscale Materials: Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement

Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

Toxicological effects assessment for wildlife in the 21st century: Review of current methods and recommendations for a path forward

New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project

Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices With Case Study Examples

Update of the DevTox Data Database for Harmonized Risk Assessment and Alternative Methodologies in Developmental Toxicology: Report of the 9th Berlin Workshop on Developmental Toxicity.

Trust your gut: Establishing confidence in gastrointestinal models - An overview of the state of the science and contexts of use

A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals

Public views of animal testing and alternatives in chemical risk assessment

25th anniversary of the Berlin workshop on developmental toxicology: DevTox database update, challenges in risk assessment of developmental neurotoxicity and alternative methodologies in bone development and growth.

Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals

Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs

Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

Using emerging science to inform risk characterizations for wildlife within current regulatory frameworks